Institution of a Subset of the Claims Challenged in an IPR Does Not Thwart Congress’ Efficiency Goal

Jan 26, 2017

Reading Time : 1 min

The DOJ argued, inter alia, that the PTAB’s decision to institute review on some, but not all, of the claims thwarts Congress’ intent that the IPR process be an “efficient system for challenging patents that should not have issued.” The DOJ relied heavily on statements from the legislative history of the America Invests Act (AIA), including views from senators who stated that, in order to meet the efficiency goal, IPR proceedings “should generally serve as a complete substitute for at least some phase of the litigation.” Because the DOJ would be required to litigate both in district court (for at least Claim 13) and before the PTAB, it argued that Congress’ goals were not met.

The PTAB disagreed and stated that it had discretion to institute on fewer than all grounds “for reasons of administrative expediency to ensure timely completion of the instituted proceeding.” The PTAB also cited Federal Circuit precedent, stating that the regulations were an exercise of the PTO’s rulemaking authority and that its interpretation of the statute was reasonable. In sum, the PTAB held that it had not “overlooked or misapprehended Congress’ goal of creating an ‘efficient system for challenging patents that should not have issued.’”

Share This Insight

Previous Entries

IP Newsflash

March 12, 2026

The Northern District of Illinois recently dismissed a complaint without prejudice for failing to plausibly allege patent infringement. The court found that the allegations of direct infringement were insufficiently pled where the images of the accused product included in the complaint did not appear to show a particular necessary element of the claims.

...

Read More

IP Newsflash

March 12, 2026

The District of New Jersey recently denied the litigants’ request for a briefing schedule to resolve a dispute about a proposed discovery confidentiality order, and also denied extending the deadlines for the defendants’ invalidity and non-infringement contentions. At issue was the scope of the FDA and patent prosecution bars in the confidentiality order.

...

Read More

IP Newsflash

February 27, 2026

The USPTO Director denied a patent owner’s request for discretionary denial of two inter partes review (IPR) petitions, citing the petitioner’s “well-settled expectation” that it would not be accused of infringing the two challenged patents. The Director’s conclusion was based on the petitioner’s decade-long business relationship with the original owner of the challenged patents.

...

Read More

IP Newsflash

February 24, 2026

The Southern District of Florida recently dismissed a complaint without prejudice because the allegations used a form of “shotgun pleading.” The court explained that a shotgun pleading includes those where every count incorporates every preceding paragraph into each cause of action, and that dismissal of such pleadings was required under Eleventh Circuit precedent.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.